dailypolitical.com
Neutralwww.dailypolitical.com ·
lemaitre vascular q1 earnings call highlights
TAX_FNCACT_MANAGERTAX_FNCACT_MANAGERSTAX_ETHNICITY_AUSTRALIANWB_135_TRANSPORT
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedLeMaitre Vascular's Q1 earnings show strong organic growth and margin expansion, driven by the Artegraft franchise. The company is investing in sales force expansion and international regulatory approvals. No significant supply chain or scarcity issues are indicated; the impact is company-specific and positive for margins.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Q1 2026 sales growth of 11%
- Gross margin 72.7%
- EPS up 42%
- Artegraft franchise sales up 36% worldwide
- Full-year revenue guidance $280 million (12% organic growth)